Product
T3D-959
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-01-20